Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Couchbase, Inc. | Director | Common Stock | 2.69M | $38.1M | $14.16 | Sep 19, 2024 | North Bridge VenturePartners 7, L.P. |
Couchbase, Inc. | Director | Common Stock | 1.99M | $28.1M | $14.16 | Sep 19, 2024 | North Bridge VenturePartners VI, L.P. |
Markforged Holding Corp | Director | Common Stock | 29.1M | $12.5M | $0.43 | Jun 24, 2024 | By: North Bridge Venture Partners 7, L.P. |
Couchbase, Inc. | Director | Common Stock | 85.9K | $1.22M | $14.16 | Sep 19, 2024 | Direct |
Markforged Holding Corp | Director | Common Stock | 464K | $200K | $0.43 | Jun 24, 2024 | Direct |
Markforged Holding Corp | Director | Earnout Shares | 2.63M | Jun 24, 2024 | By: North Bridge Venture Partners 7, L.P | ||
Lyra Therapeutics, Inc. | Director, 10%+ Owner | Stock Option | 20K | Jun 30, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
BASE | Couchbase, Inc. | Sep 19, 2024 | 1 | $298K | 4 | Sep 23, 2024 | Director |
BASE | Couchbase, Inc. | Sep 16, 2024 | 1 | $0 | 4 | Sep 18, 2024 | Director |
MKFG | Markforged Holding Corp | Jun 24, 2024 | 1 | $112K | 4 | Jun 26, 2024 | Director |
BASE | Couchbase, Inc. | Jun 17, 2024 | 1 | $0 | 4 | Jun 20, 2024 | Director |
BASE | Couchbase, Inc. | May 30, 2024 | 1 | $0 | 4 | Jun 3, 2024 | Director |
BASE | Couchbase, Inc. | Mar 15, 2024 | 1 | $0 | 4 | Mar 19, 2024 | Director |
BASE | Couchbase, Inc. | Dec 15, 2023 | 1 | $0 | 4 | Dec 19, 2023 | Director |
BASE | Couchbase, Inc. | Sep 15, 2023 | 1 | $0 | 4 | Sep 19, 2023 | Director, 10%+ Owner |
LYRA | Lyra Therapeutics, Inc. | Jun 30, 2023 | 1 | $0 | 4 | Jul 5, 2023 | Director, 10%+ Owner |
MKFG | Markforged Holding Corp | Jun 20, 2023 | 1 | $150K | 4 | Jun 22, 2023 | Director |
BASE | Couchbase, Inc. | Jun 15, 2023 | 1 | $0 | 4 | Jun 16, 2023 | Director, 10%+ Owner |
BASE | Couchbase, Inc. | Jun 1, 2023 | 1 | $0 | 4 | Jun 5, 2023 | Director, 10%+ Owner |
LYRA | Lyra Therapeutics, Inc. | May 31, 2023 | 6 | $4.5M | 4 | Jun 2, 2023 | Director, 10%+ Owner |
BASE | Couchbase, Inc. | Mar 15, 2023 | 1 | $0 | 4 | Mar 17, 2023 | Director, 10%+ Owner |
BASE | Couchbase, Inc. | Dec 15, 2022 | 1 | $0 | 4 | Dec 19, 2022 | Director, 10%+ Owner |
BASE | Couchbase, Inc. | Sep 15, 2022 | 1 | $0 | 4 | Sep 19, 2022 | Director, 10%+ Owner |
MKFG | Markforged Holding Corp | Jun 21, 2022 | 1 | $150K | 4 | Jun 27, 2022 | Director |
LYRA | Lyra Therapeutics, Inc. | Jun 16, 2022 | 1 | $0 | 4 | Jun 21, 2022 | Director, 10%+ Owner |
BASE | Couchbase, Inc. | Jun 15, 2022 | 2 | $0 | 4 | Jul 6, 2022 | Director |
LYRA | Lyra Therapeutics, Inc. | Apr 12, 2022 | 4 | $10.5M | 4 | Apr 14, 2022 | Director, 10%+ Owner |
BASE | Couchbase, Inc. | Jul 26, 2021 | 19 | $4M | 4 | Jul 26, 2021 | Director, 10%+ Owner |
BASE | Couchbase, Inc. | Jul 21, 2021 | 0 | $0 | 3 | Jul 21, 2021 | Director, 10%+ Owner |
MKFG | Markforged Holding Corp | Jul 14, 2021 | 0 | $0 | 3 | Jul 14, 2021 | Director, 10%+ Owner |
LYRA | Lyra Therapeutics, Inc. | May 26, 2021 | 1 | $0 | 4 | May 28, 2021 | Director |